NDAORALTABLET
Approved
Nov 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
21
Mechanism of Action
Phosphodiesterase 5 Inhibitors
Pharmacologic Class:
Phosphodiesterase 5 Inhibitor
Clinical Trials (5)
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
Started Feb 2026
40 enrolled
Asthma AttackAsthma ControlAsthma Exacerbations+1 more
Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
Started Dec 2025
600 enrolled
AsthmaCOPD
Actual Use Trial of Tadalafil 5 mg
Started Jan 2025
2,250 enrolled
Erectile Dysfunction
Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain
Started Jun 2024
33 enrolled
Severe Asthma
Burnout Syndrome Among Diabetes Specialist Trainee Registrars in United Kingdom
Started Jul 2022
104 enrolled
Burnout, ProfessionalWork-Related Condition